Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides
文献类型:期刊论文
作者 | Lin, Tingting1,2; Liu, Ergang1,2; He, Huining1; Shin, Meong Cheol3,4,5; Moon, Cheol6; Yang, Victor C.1,3; Huang, Yongzhuo2 |
刊名 | ACTA PHARMACEUTICA SINICA B |
出版日期 | 2016-07 |
卷号 | 6期号:4页码:352-358 |
ISSN号 | 2211-3835 |
关键词 | Intranasal protein delivery Brain targeting Cell-penetrating peptide Low molecular weigh protamine Blood brain barrier |
DOI | 10.1016/j.apsb.2016.04.001 |
文献子类 | Article |
英文摘要 | Brain delivery of macromolecular therapeutics (e.g., proteins) remains an unsolved problem because of the formidable blood brain bather (BBB). Although a direct pathway of nose-to-brain transfer provides an answer to circumventing the BBB and has already been intensively investigated for brain delivery of small drugs, new challenges arise for intranasal delivery of proteins because of their larger size and hydrophilicity. h order to overcome the bathers and take advantage of available pathways (e.g., epithelial tight junctions, uptake by olfactory neurons, transport into brain tissues, and intra-brain diffusion), a low molecular weight protamine (LMWP) cell-penetrating peptide was utilized to facilitate nose-to-brain transport. Cell-penetrating peptides (CPP) have been widely used to mediate macromolecular delivery through many kinds of biobarriers. Our results show that conjugates of LMWP proteinsare able to effectively penetrate into the brain after intranasal administration. The CPP-based intranasal method highlights a promising solution for protein therapy of brain diseases. (C) 2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. |
WOS关键词 | MOLECULAR-WEIGHT PROTAMINE ; IN-VIVO EVALUATION ; PROTEIN TRANSDUCTION ; ASPARAGINASE THERAPY ; HEPARIN ANTAGONIST ; DRUG-DELIVERY ; VITRO ; SYSTEM ; ABSORPTION ; EFFICIENT |
资助项目 | National Basic Research Program of China (973 Program)[2013CB932503] ; National Basic Research Program of China (973 Program)[2014CB931900] ; National Natural Science Foundation of China[81172996] ; National Natural Science Foundation of China[81373357] ; National Natural Science Foundation of China[81422048] ; National Natural Science Foundation of China[81361140344] |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
CSCD记录号 | CSCD:5751696 |
出版者 | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES |
WOS记录号 | WOS:000384896100012 |
源URL | [http://119.78.100.183/handle/2S10ELR8/275964] |
专题 | 药物制剂研究中心 |
通讯作者 | Yang, Victor C.; Huang, Yongzhuo |
作者单位 | 1.Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China; 2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; 3.Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA; 4.Gyeongsang Natl Univ, Coll Pharm, Jinju 660701, Gyeongnam, South Korea; 5.Gyeongsang Natl Univ, Pharmaceut Sci Res Inst, Jinju 660701, Gyeongnam, South Korea; 6.Sunchon Natl Univ, Coll Pharm, Sunchon 540950, Jeonnam, South Korea |
推荐引用方式 GB/T 7714 | Lin, Tingting,Liu, Ergang,He, Huining,et al. Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides[J]. ACTA PHARMACEUTICA SINICA B,2016,6(4):352-358. |
APA | Lin, Tingting.,Liu, Ergang.,He, Huining.,Shin, Meong Cheol.,Moon, Cheol.,...&Huang, Yongzhuo.(2016).Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides.ACTA PHARMACEUTICA SINICA B,6(4),352-358. |
MLA | Lin, Tingting,et al."Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides".ACTA PHARMACEUTICA SINICA B 6.4(2016):352-358. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。